Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Clinical Medicine Research Center for Hepatic Surgery of Hubei Province, Wuhan, Hubei, PR China.
Aging (Albany NY). 2021 Jun 1;13(11):15214-15239. doi: 10.18632/aging.203081.
The differential expression of chromosome 12 open reading frame 75 () is closely related with cancer progression. Here, we studied the expression levels of and investigated its prognostic value in various cancers across distinct datasets including ONCOMINE, PrognoScan, GEPIA, and TCGA. The correlation between genetic alteration of C12orf75 and immune infiltration was investigated using the cBioPortal and TIMER databases. RNA interference was used to verify the influence of knockdown on the biological phenotype of hepatocellular carcinoma cells. C12orf75 showed increased expression in most tested human cancers. The increased expression of was related with a poor prognosis in urothelial bladder carcinoma and hepatocellular liver carcinoma, but it was surprisingly converse in renal papillary cell carcinoma. In urothelial bladder carcinoma and hepatocellular liver carcinoma, we observed positive correlations between the expression of and the infiltration of immune cells, including B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells. The knockdown of in hepatocellular carcinoma cells suppressed the proliferation, migration, and invasion and arrested the cell cycle. This is the first report has potential as a prognostic biomarker and therapeutic target for molecularly targeted drugs in urothelial bladder carcinoma, hepatocellular liver carcinoma, and renal papillary cell carcinoma.
染色体 12 开放阅读框 75() 的差异表达与癌症进展密切相关。在这里,我们研究了 的表达水平,并在包括 ONCOMINE、PrognoScan、GEPIA 和 TCGA 在内的不同数据集研究了其在各种癌症中的预后价值。使用 cBioPortal 和 TIMER 数据库研究了 C12orf75 基因改变与免疫浸润的相关性。使用 RNA 干扰验证了 敲低对肝癌细胞生物学表型的影响。C12orf75 在大多数测试的人类癌症中表达增加。 的表达增加与膀胱癌和肝癌的预后不良有关,但在肾乳头细胞癌中却出人意料地相反。在膀胱癌和肝癌中,我们观察到 与免疫细胞浸润之间存在正相关,包括 B 细胞、CD8+T 细胞、CD4+T 细胞、巨噬细胞、嗜中性粒细胞和树突状细胞。肝癌细胞中 的敲低抑制了增殖、迁移和侵袭,并使细胞周期停滞。这是首次报道 作为膀胱癌、肝癌和肾乳头细胞癌的分子靶向药物的预后生物标志物和治疗靶点具有潜力。